semaglutide to dulaglutide conversion Comparative effectiveness of and combined with hypocaloric diet in newly diagnosed type 2 diabetes: a retrospective real-world study | BMC Endocrine Disorders Sleeve-to-bypass conversion vs. sleeve-with-adjuvant GLP-1

The study reached 2 primary endpoints: The main statistical methods showed that in all randomized patients, after 68 weeks of treatment, the SC semaglutide 2.4mg treatment group lost 14.9% from the average baseline weight of 105.3 kg, the placebo group lost 2.4%, and the SC semaglutide 2.4mg group had 86.4%

At present, both in vivo and in vitro research on the chemoprotective properties of ATX is in its early stages

More rigorous reproduction research is necessary to verify any fertility advantage

EPA/DHA combination doses greater than 1 gram and DHA doses greater than 580 mg per day were needed for these benefits to be significant